Taysha Gene Therapies
TSHA
#5605
Rank
A$1.79 B
Marketcap
A$6.56
Share price
-4.50%
Change (1 day)
145.18%
Change (1 year)

EPS for Taysha Gene Therapies (TSHA)

EPS in 2025 (TTM): A-$0.55

According to Taysha Gene Therapies's latest financial reports the company's current EPS (TTM) is A-$0.51. In 2022 the company made an earnings per share (EPS) of A-$5.35 an increase over its 2021 EPS that were of A-$6.50.

EPS history for Taysha Gene Therapies from 2021 to 2025

Annual EPS

Year EPS Change
2025 (TTM)A-$0.55
2022A-$5.35-17.71%
2021A-$6.50

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
ORIC Pharmaceuticals
ORIC
A-$2.43 380.56%๐Ÿ‡บ๐Ÿ‡ธ USA